Quadrant Capital Group’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-267
| Closed | -$7.38K | – | 2722 |
|
|
2023
Q4 | $7.38K | Buy |
267
+259
| +3,238% | +$15.8K | ﹤0.01% | 2170 |
|
|
2023
Q3 | $460 | Hold |
8
| – | – | ﹤0.01% | 2578 |
|
|
2023
Q2 | $497 | Hold |
8
| – | – | ﹤0.01% | 2570 |
|
|
2023
Q1 | $481 | Buy |
8
+5
| +167% | +$571 | ﹤0.01% | 2610 |
|
|
2022
Q4 | $408 | Buy |
+3
| New | +$423 | ﹤0.01% | 2647 |
|
|
2022
Q2 | – | Sell |
-6
| Closed | -$1K | – | 2538 |
|
|
2022
Q1 | $1K | Buy |
6
+3
| +100% | +$396 | ﹤0.01% | 2251 |
|
|
2021
Q4 | $1K | Sell |
3
-2
| -40% | -$472 | ﹤0.01% | 2255 |
|
|
2021
Q3 | $1K | Sell |
5
-36
| -88% | -$10.3K | ﹤0.01% | 2257 |
|
|
2021
Q2 | $17K | Buy |
41
+26
| +173% | +$10.3K | ﹤0.01% | 1278 |
|
|
2021
Q1 | $6K | Buy |
15
+4
| +36% | +$1.97K | ﹤0.01% | 1703 |
|
|
2020
Q4 | $6K | Sell |
11
-9
| -45% | -$5.7K | ﹤0.01% | 1619 |
|
|
2020
Q3 | $14K | Buy |
20
+4
| +25% | +$3.12K | ﹤0.01% | 1094 |
|
|
2020
Q2 | $13K | Sell |
16
-37
| -70% | -$27.9K | ﹤0.01% | 1218 |
|
|
2020
Q1 | $32K | Buy |
53
+12
| +29% | +$11.7K | 0.01% | 1079 |
|
|
2019
Q4 | $46K | Buy |
41
+9
| +28% | +$9.78K | 0.01% | 1380 |
|
|
2019
Q3 | $38K | Buy |
32
+4
| +14% | +$6.11K | 0.01% | 1332 |
|
|
2019
Q2 | $45K | Sell |
28
-10
| -26% | -$17.3K | 0.01% | 1259 |
|
|
2019
Q1 | $74K | Buy |
38
+26
| +217% | +$45.8K | 0.01% | 969 |
|
|
2018
Q4 | $15K | Hold |
12
| – | – | ﹤0.01% | 1266 |
|
|
2018
Q3 | $22K | Hold |
12
| – | – | 0.01% | 932 |
|
|
2018
Q2 | $24K | Hold |
12
| – | – | 0.01% | 898 |
|
|
2018
Q1 | $26K | Hold |
12
| – | – | 0.01% | 850 |
|
|
2017
Q4 | $27K | Hold |
12
| – | – | 0.01% | 817 |
|
|
2017
Q3 | $21K | Hold |
12
| – | – | 0.01% | 880 |
|
|
2017
Q2 | $16K | Hold |
12
| – | – | 0.01% | 930 |
|
|
2017
Q1 | $14K | Hold |
12
| – | – | 0.01% | 953 |
|
|
2016
Q4 | $9K | Hold |
12
| – | – | ﹤0.01% | 1050 |
|
|
2016
Q3 | $10K | Hold |
12
| – | – | 0.01% | 1042 |
|
|
2016
Q2 | $6K | Buy |
+12
| New | +$6.8K | ﹤0.01% | 1158 |
|
|
2015
Q3 | – | Sell |
-4
| Closed | -$8K | – | 1273 |
|
|
2015
Q2 | $8K | Buy |
+4
| New | +$8.15K | 0.01% | 743 |
|
Other funds holding BLUE
GIM
PAI
TCM
Quadrant Capital Group's BLUE Position: Q1 2024 in Review
Quadrant Capital Group sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 267 shares — an estimated $7.38K sold.
Quadrant Capital Group first reported a position in BLUE in Q2 2015 and held it in 30 quarters. The position peaked at $74K in Q1 2019. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.
- Quadrant Capital Group reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
- Quadrant Capital Group sold 267 bluebird bio shares in Q1 2024, an estimated $7.38K.
- Quadrant Capital Group first reported a position in bluebird bio in Q2 2015 and held it in 30 quarters.
- Quadrant Capital Group's bluebird bio position peaked at $74K in Q1 2019.
- 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.
Based on Quadrant Capital Group's 13F filing for Q1 2024, filed 15 May 2024.